BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20878950)

  • 1. Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer.
    Sun J; Kader AK; Hsu FC; Kim ST; Zhu Y; Turner AR; Jin T; Zhang Z; Adolfsson J; Wiklund F; Zheng SL; Isaacs WB; Grönberg H; Xu J
    Prostate; 2011 Mar; 71(4):421-30. PubMed ID: 20878950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of absolute risk for prostate cancer using genetic markers and family history.
    Xu J; Sun J; Kader AK; Lindström S; Wiklund F; Hsu FC; Johansson JE; Zheng SL; Thomas G; Hayes RB; Kraft P; Hunter DJ; Chanock SJ; Isaacs WB; Grönberg H
    Prostate; 2009 Oct; 69(14):1565-72. PubMed ID: 19562736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.
    Conran CA; Na R; Chen H; Jiang D; Lin X; Zheng SL; Brendler CB; Xu J
    Asian J Androl; 2016; 18(4):520-4. PubMed ID: 27080480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial.
    Chen H; Na R; Packiam VT; Conran CA; Jiang D; Tao S; Yu H; Lin X; Meng W; Zheng SL; Brendler CB; Helfand BT; Xu J
    Prostate; 2017 Aug; 77(11):1179-1186. PubMed ID: 28670847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.
    Ren S; Xu J; Zhou T; Jiang H; Chen H; Liu F; Na R; Zhang L; Wu Y; Sun J; Yang B; Gao X; Zheng SL; Xu C; Ding Q; Sun Y
    Prostate; 2013 Dec; 73(16):1824-35. PubMed ID: 24037738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis.
    Na R; Labbate C; Yu H; Shi Z; Fantus RJ; Wang CH; Andriole GL; Isaacs WB; Zheng SL; Helfand BT; Xu J
    JAMA Netw Open; 2019 Dec; 2(12):e1918145. PubMed ID: 31880795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases.
    Na R; Ye D; Qi J; Liu F; Lin X; Helfand BT; Brendler CB; Conran C; Gong J; Wu Y; Gao X; Chen Y; Zheng SL; Mo Z; Ding Q; Sun Y; Xu J
    Asian J Androl; 2016; 18(4):525-9. PubMed ID: 27140652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
    Nordström T; Aly M; Eklund M; Egevad L; Grönberg H
    Eur Urol; 2014 Jun; 65(6):1184-90. PubMed ID: 23891454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation.
    Kim ST; Cheng Y; Hsu FC; Jin T; Kader AK; Zheng SL; Isaacs WB; Xu J; Sun J
    Prostate; 2010 Dec; 70(16):1729-38. PubMed ID: 20564319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.
    Liss MA; Xu J; Chen H; Kader AK
    Prostate; 2015 Sep; 75(12):1322-8. PubMed ID: 25982801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validity and utility of genetic risk scores in prostate cancer.
    Helfand BT; Kearns J; Conran C; Xu J
    Asian J Androl; 2016; 18(4):509-14. PubMed ID: 27297129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in oxidative stress pathway genes and prostate cancer risk.
    Zhang Z; Jiang D; Wang C; Garzotto M; Kopp R; Wilmot B; Thuillier P; Dang A; Palma A; Farris PE; Shannon J
    Cancer Causes Control; 2019 Dec; 30(12):1365-1375. PubMed ID: 31667711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
    Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
    Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of 8 loci on chromosome 8q24 with prostate carcinoma risk in northern Chinese men.
    Zhao CX; Liu M; Wang JY; Xu Y; Wei D; Yang K; Yang Z
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6733-8. PubMed ID: 24377597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history.
    Hsu FC; Sun J; Zhu Y; Kim ST; Jin T; Zhang Z; Wiklund F; Kader AK; Zheng SL; Isaacs W; Grönberg H; Xu J
    Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1083-8. PubMed ID: 20332264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci.
    Chen H; Yu H; Wang J; Zhang Z; Gao Z; Chen Z; Lu Y; Liu W; Jiang D; Zheng SL; Wei GH; Issacs WB; Feng J; Xu J
    Prostate; 2015 Sep; 75(12):1264-76. PubMed ID: 26015065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese.
    Liu J; Song B; Bai X; Liu W; Li Z; Wang J; Zheng Y; Wang Z
    BMC Cancer; 2010 Aug; 10():456. PubMed ID: 20735825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic factors influencing prostate cancer risk in Norwegian men.
    Chen H; Ewing CM; Zheng S; Grindedaal EM; Cooney KA; Wiley K; Djurovic S; Andreassen OA; Axcrona K; Mills IG; Xu J; Maehle L; Fosså SD; Isaacs WB
    Prostate; 2018 Feb; 78(3):186-192. PubMed ID: 29181843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
    Setlur SR; Chen CX; Hossain RR; Ha JS; Van Doren VE; Stenzel B; Steiner E; Oldridge D; Kitabayashi N; Banerjee S; Chen JY; Schäfer G; Horninger W; Lee C; Rubin MA; Klocker H; Demichelis F
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):229-39. PubMed ID: 20056642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of THADA, FOXP4, GPRC6A/RFX6 genes and 8q24 risk alleles with prostate cancer in Northern Chinese men.
    Li XH; Xu Y; Yang K; Shi JJ; Zhang X; Yang F; Yuan H; Zhu X; Zhang YH; Wang JY; Yang Z
    J BUON; 2015; 20(5):1223-8. PubMed ID: 26537068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.